Urea

Urea

SCHEMBL21612151

NC(N)=O.NSN.Nc1cccnc1C=O

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RRM2 P31350 2/20 0.45
RRM1 P23921 1/20 0.45
RRM2B Q7LG56 1/20 0.45
CISD1 Q9NZ45 1/20 0.45
NAPRT Q6XQN6 1/20 0.37
MKNK1 Q9BUB5 1/20 0.35
MKNK2 Q9HBH9 1/20 0.35
HDAC3 O15379 1/20 0.35
HDAC4 P56524 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC7 Q8WUI4 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC10 Q969S8 1/20 0.35
HDAC11 Q96DB2 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
HDAC9 Q9UKV0 1/20 0.35
HDAC5 Q9UQL6 1/20 0.35
TRIM24 O15164 1/20 0.34
TRIM33 Q9UPN9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Urea SCHEMBL28153660 0.95 RRM2 (0.49) RRM2RRM1RRM2BCISD1NAPRT
Urea SCHEMBL21612150 0.91 RRM2 (0.46) RRM2RRM1RRM2BCISD1NAPRT
SCHEMBL1501696 0.87
Thiourea SCHEMBL28502228 0.86 RRM2 (0.55) RRM2RRM1RRM2BCISD1NAPRT
Hydrogen Sulfide SCHEMBL28281811 0.85 RRM1 (0.45) RRM2RRM1RRM2BCISD1NAPRT
Thiosemicarbazide SCHEMBL27702929 0.80 RRM2 (0.57) RRM2RRM1RRM2BCISD1HDAC3
Trifluoroacetic Acid SCHEMBL3213348 0.80 HTT (0.40) RRM2RRM1RRM2BCISD1NAPRT
SCHEMBL29113020 0.77 RRM2 (0.54) RRM2RRM1RRM2BCISD1NAPRT
Phenylthiourea SCHEMBL28693164 0.74 ALDH1A1 (0.53) RRM2RRM1RRM2BCISD1SMN1; SMN2
SCHEMBL14125804 0.73 PARP1 (0.53) NAPRTPARP1LMNASMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020007106-A1 MEDICAL USE OF EVOFOSFAMIDE IN ANTI-CANCER 深圳艾欣达伟医药科技有限公司 2020-01-09 WO disclosed